Lancet Global Health

Article	Citations
Correction to Lancet Glob Health 2021; 9: e1679–87	1046
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study	413
Indonesia's first nationwide health screening programme	408
The drug drought in maternal health: an ongoing predicament	365
The cause of nodding syndrome remains unknown	347
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6	337
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial	322
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study	298
Mpox vaccination strategies in DR Congo	286
C-reactive protein: another addition to our armamentarium against tuberculosis?	273
Is now the time for revisiting supplements for pregnant women?	260
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications	260
The road to malaria elimination: why a robust surveillance system is imperative	197
Expanding access to long-acting HIV therapy in low-income and middle-income countries	189
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study	181
Resolving the CD4-testing crisis to help end AIDS-related deaths	177
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial	173
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis	171
The health status of Indonesia's provinces: the double burden of diseases and inequality gap	169
Bringing home manufacturing of medical products	168
Preventing pellagra during isoniazid preventive treatment	167
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis	166
Racism and health: the need for urgent action	158
The future of the International Health Regulations	156
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)	156

Influenza vaccination in failing hearts	154
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply	150
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis	149
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study	144
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study	140
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor	134
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou	133
Global patterns and trends in Kaposi sarcoma incidence: a population-based study	129
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study	129
Global health research funding applications: brain drain under another name?	121
Challenges in operationalising clinical trials in India during the COVID-19 pandemic	114
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study	112
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr	111
Outcomes of rheumatic fever in Uganda: a prospective cohort study	109
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m	107
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys	106
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019	105
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial	104
Routine immunisation coverage in the context of seasonal influenza vaccine introduction for children in Nakuru and Mombasa counties in Kenya, 2019–21: an observational study	103
Payment in arrears: a global health inequity that must be corrected	96
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine	94
Lessons for future implementation of the E-MOTIVE bundle	92
Improving access to liposomal amphotericin B worldwide	92
Correction to Lancet Glob Health 2023; 11: e1978–85	91
Experiences of an Israeli hospital in the management of repatriated civilian hostages	91
Bridging the gap between science and policy in global health governance	90
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer	90
Using theory to understand how interventions work and inform future implementation	88
Uncertainty in key population size estimates in sub-Saharan Africa	87
Using verbal autopsy to enhance mortality surveillance	87
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned	86
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research	85
Changes in incidence of HPV-related cancers in South Africa (2011–21): a cross-sectional analysis of the South African National Cancer Registry	84
Correction to Lancet Glob Health 2015; 3: e196	82
Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995–2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023	82
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:	82
Climate change and health: the next challenge of ethical AI	81
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation	81
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study	81
Understanding deaths from diarrhoea in children younger than 5 years	79
The social determinants of tuberculosis in the Philippines	79
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security	79
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review	78
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden	78
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns	78
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026	74
How to DREAMM and end HIV-related deaths	73
Next generation economics of universal HIV treatment	72
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition	72
Cholera rapid diagnostic tests recycled for PCR confirmation	71

Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–20	71
From child institutions to family reunification: challenges and opportunities in building family-centred care	70
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control	69
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply	69
Correction to Lancet Glob Health 2022; 10: e1443–52	69
Addressing the social inequities of vaccination: an imperative to close the gap	67
Cervical cancer elimination: actions needed in the COVID-19 era	66
Highlighting the need for investment and innovation in ART retention interventions	66
Commitment and innovation on the road to people-centred PHC financing	65
Infertility—why the silence?	63
Addressing the complex needs of people with severe mental health disorders in low-resource settings	63
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all	62
Achieving sensible targets for a diabetes care cascade in LMICs	62
Pregnancy in people who have survived Ebola virus disease	60
Mpox: evidence for strengthening and sustaining global surveillance	59
Staying focused on protecting young people from the harms of tobacco smoke	59
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement	57
Impact of excluded studies on medical male circumcision and HIV risk compensation	57
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study	56
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial	56
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis	54
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation	53
Characterisation of febrile non-traumatic coma in sub-Saharan Africa	53
Reducing antibiotic use with diarrhoeal vaccines	52
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled t	52
Addressing global micronutrient inadequacies: enhancing global data representation	52
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings	52
Every baby counts: eliminating all preventable child deaths	52
Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health	52
AI for health or AI for war? Challenging the military partnerships behind climate harm	52
Maternal intimate partner violence and child health outcomes	51
Low risk, high impact: the hidden burden of cardiovascular disease	49
Equity challenges in Indonesian health care	49
Identifying gaps in the HIV treatment cascade in Africa: a model comparison study	47
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries:	47
Precision in prescription: multiple micronutrient supplements in pregnancy	47
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study	46
People who inject drugs in the Eastern Mediterranean region	46
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis	46
Pulse oximetry to detect paediatric hypoxaemia—the fifth vital sign	46
Unveiling the crisis of the double burden of malnutrition	46
COVID-19 in pregnancy: evidence from LMICs	45
Migrants and displaced people: intentionally endangered and inconsistently visible	45
Lots of considerations when evaluating the FujiLAM assay – Author's reply	44
Reciprocal innovation: a new approach to equitable and mutually beneficial global health research and partnerships	43
Withholding liberty, not the right to health	43
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) regi	43
Correction to Lancet Glob Health 2022; 10: e1115–27	43
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le	42
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data	42
The landscape for rare diseases in 2024	42
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipaliti	42
Correction to Lancet Glob Health 2024; 12: e1389–90	41
Can resistance testing improve outcomes for children and adolescents with HIV?	41
Policy and service delivery proposals to improve primary care services in low-income and middle-income country cities	40
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort	40
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study	40
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study	40
Quartile-based risk exposure in global IHD and ischaemic stroke	40
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries	39
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort	39
How the EAT–Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication	39
The challenge of promoting physical activity in low-income and middle-income countries	38
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India	38
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis	38
Tuberculosis and undernutrition in India – Authors’ reply	37
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study	37
Can the ShangRing bring us closer to endorsing early infant male circumcision in sub-Saharan Africa?	37
Donor aid and research funding for newborn babies and preventing stillbirths	37
Innovative methods of determining health expenditure efficiency are urgently needed	37
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region	37
Universal health coverage is fundamental to preparing for a healthier and better tomorrow	37
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem	36
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake	36
Wastewater monitoring can anchor global disease surveillance systems	36
Avoiding another lost decade in reducing malaria burden in African infants and young children	36
Homing in on haemoglobinopathies	35
Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study	35
Impact of excluded studies on medical male circumcision and HIV risk compensation – Authors' reply	35
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries	35

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines	35
Climate change and the right to health of people with disabilities	35
Insights from Zimbabwe's SARS-CoV-2 genomic surveillance	35
Navigating AMR with innovative diagnostics	34
Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study	34
Nodding syndrome and doxycycline: promising findings with open questions	34
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories	34
Balancing global access to opioids	33
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action	33
Individual-level and community-level factors for 10-year cardiovascular disease risk in Ethiopia: a retrospective, population-based, cross-sectional, observational study	33
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study	33
Aminoglycosides, deafness, and non-tuberculous mycobacteria	33
Relapse after recovery from acute malnutrition	33
Urgent call for the prioritisation of palliative care in Syria	33
Catastrophic health expenditure and chronic respiratory disease: evidence from Kenya	32
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings	32
Correction to Lancet Glob Health 2025; 13: e309–18	32
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study	32
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction – Authors' reply	32
Neonatal mortality during the war in Tigray: a cross-sectional community-based study	32
Correction to Lancet Glob Health 2025; 13: e528–84	32
Mpox vaccination strategies in DR Congo	32
The continuum of menstrual health through the life course	32
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research	31
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial	31
The health toll of economic sanctions	31
Integrating mental health care to reduce intimate partner violence in complex humanitarian emergencies	31
Correction to Lancet Glob Health 2022; 10: 1715–43	30
The challenging road to universal health coverage	30
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study	30
Defining the usefulness of oral swabs in tuberculosis diagnosis	30
Combating antimicrobial resistance in neonatal infections: a South African perspective	30
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study	30
Targeting malaria control to schoolchildren	30
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial	30
The SARS-CoV2 pandemic and routine immunisation	29
Finding balance in Nigeria's mandatory health insurance	29
Enabling access to quality abortion care: WHO's Abortion Care guideline	29
Prevention of pneumococcal diseases: the challenge remains	29
Postnatal morbidity: prevalent, enduring, and neglected	29
Questions about the HELIX trial	29
Colorectal cancer screening with fecal immunochemical testing in Nigeria – Authors' reply	29
Enhancing cervical and breast cancer training in Africa with e-learning	29
National diabetes prevention programmes in LMICs are now a necessity	29
Colorectal cancer screening in sub-Saharan Africa	29
Global variations in barriers to exercise for individuals with intellectual and developmental disability	28
Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial	28
The need for a One Health approach for influenza surveillance	28
Trans Reform: an initiative for the recognition of transgender rights in a university in Lima, Peru	28
Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors	28
Pragmatic global health	28
Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries	28
Ethical considerations for introducing RTS,S/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission	28
Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional s	28
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial	27
Strengthening health-care systems to reduce child mortality	27
Evolving crises and unprecedented need: research on health in humanitarian settings must not be overlooked	27
Global, regional, and national causes of death in children and adolescents younger than 20 years: an open data portal with estimates for 2000–21	27
Correction to Lancet Glob Health 2024; 12: e1209–13	27
Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older	27
Clearing our heads over alcohol	27
Prediabetes: the best opportunity to reach remission	27
Indigenous and minority groups in diabetes trials	26
Bridging the divide between religion and health care	26
What can we learn from developments in primary health care in south Asia?	26
Socioeconomic inequalities in palliative care access: insights from SHARE	26
Correction to Lancet Glob Health 2024; 12: e25–27	26
Peripheral artery disease: a global need for detection, prevention, and treatment	26
Maximising the value of nudge units for global health	26
Postpartum maternal and infant haematological effects of second-trimester ferric carboxymaltose versus standard-of-care oral iron in Malawi: longitudinal follow-up of a randomised controlled trial	26
Monitoring the benefits of human papillomavirus vaccination in low-income and middle-income countries	26
Are current systems of global health academia fit for purpose?	26
Malaria guidelines fall short in diagnosing acute kidney injury	26
Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgame	26
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance	26
Mpox outbreaks in Africa constitute a public health emergency of continental security	26
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats	26
Exposure to household air pollution from cooking fuel in Ugandan households and associated household factors: a retrospective analysis of demographic and health survey data	25
Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectiona	25
Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators	25
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study	25
Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: a mathematical modelling study	25
Correction to Lancet Glob Health 2021; 9: e1610–17	25
Short-term aid or long-term gains? Harnessing Sudan's humanitarian response for the resilience of its health system	25
Democratising clinical trials research to strengthen primary health care	25
Nigeria's mandatory health insurance and the march towards universal health coverage	25
Estimating dementia prevalence using remote diagnoses and algorithmic modelling: a population-based study of a rural region in South Africa	25
A call to action: the global failure to effectively tackle maternal mortality rates	25
Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010–23	25
Redefining implementation science for global health decolonisation	25
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care	25
The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice	25
Addressing the adherence challenge in tuberculosis treatment: more than digital technologies	24
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study	24
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis	24